Divergent downstream biosynthetic pathways are supported by L-cysteine synthases of Mycobacterium tuberculosis
eLife · 2024
DOI: 10.7554/elife.91970 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2024. Verfasst von Mehak Zahoor Khan und 9 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Immunology, New Delhi, India. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Cysteine, Cysteine Synthase, Biosynthetic Pathways. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Engineering Research Board, Department of Biotechnology, Ministry of Science and Technology, India, Cancer Research UK.
Abstract (Originalsprache)
Mycobacterium tuberculosis ’s ( Mtb ) autarkic lifestyle within the host involves rewiring its transcriptional networks to combat host-induced stresses. With the help of RNA sequencing performed under various stress conditions, we identified that genes belonging to Mtb sulfur metabolism pathways are significantly upregulated during oxidative stress. Using an integrated approach of microbial genetics, transcriptomics, metabolomics, animal experiments, chemical inhibition, and rescue studies, we investigated the biological role of non-canonical L -cysteine synthases, CysM and CysK2. While transcriptome signatures of RvΔcysM and RvΔcysK2 appear similar under regular growth conditions, we observed unique transcriptional signatures when subjected to oxidative stress. We followed pool size and labelling ( 34 S) of key downstream metabolites, viz. mycothiol and ergothioneine, to monitor L-cysteine biosynthesis and utilization. This revealed the significant role of distinct L-cysteine biosynthetic routes on redox stress and homeostasis. CysM and CysK2 independently facilitate Mtb survival by alleviating host-induced redox stress, suggesting they are not fully redundant during infection. With the help of genetic mutants and chemical inhibitors, we show that CysM and CysK2 serve as unique, attractive targets for adjunct therapy to combat mycobacterial infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Institute of Immunology, New Delhi, India.
- CSIR-Centre for Cellular and Molecular Biology, Hyderabad, India.
- The Francis Crick Institute, London, United Kingdom.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.
- Department of Pharmacy, Birla Institute of Technology and Science-Pilani, Hyderabad, India.
- Department of Chemistry, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Jupiter, United States.
ORCID-Profile: Yogita Kapoor, Luiz Pedro S de Carvalho, Vinay Kumar Nandicoori
Förderung
- Science and Engineering Research Board
- Department of Biotechnology, Ministry of Science and Technology, India
- Cancer Research UK
- Medical Research Council
- Wellcome Trust
Zitieren
APA
Khan, M. Z., Hunt, D. M., Singha, B., Kapoor, Y., Singh, N. K., Prasad, D. V. S., Dharmarajan, S., Sowpati, D. T., de Carvalho, L. P. S., & Nandicoori, V. K. (2024). Divergent downstream biosynthetic pathways are supported by L-cysteine synthases of Mycobacterium tuberculosis. eLife. https://doi.org/10.7554/elife.91970
Vancouver
Khan MZ, Hunt DM, Singha B, Kapoor Y, Singh NK, Prasad DVS, et al. Divergent downstream biosynthetic pathways are supported by L-cysteine synthases of Mycobacterium tuberculosis. eLife. 2024. doi:10.7554/elife.91970
BibTeX
@article{Khan2024,
author = {Khan, Mehak Zahoor and Hunt, Debbie M and Singha, Biplab and Kapoor, Yogita and Singh, Nitesh Kumar and Prasad, D V Sai and Dharmarajan, Sriram and Sowpati, Divya Tej and de Carvalho, Luiz Pedro S and Nandicoori, Vinay Kumar},
title = {Divergent downstream biosynthetic pathways are supported by L-cysteine synthases of Mycobacterium tuberculosis},
journal = {eLife},
year = {2024},
doi = {10.7554/elife.91970}
}
EUVIMED